Respiratory Metagenomics Expansion Programme

Authority: Guy's and St Thomas' NHS Foundation Trust (Central government)

Direct award

Sectors: Software Packages & ERP (48)Architecture & Engineering (71)Research & Development (R&D) (73) Delivery: Delivery location not published

Awarded value£7,010,966published award · exc. VAT

Awarded 21 Nov 2025no call for competition

Awarded to Oxford Nanopore Technologies2 awards

What is being bought

Published requirement description

GSTT will lead the development of a national clinical metagenomics pilot service by deploying NHS developed laboratory, bioinformatic and clinical protocols along with Oxford Nanopore developed sequencing technology to a network of 30 NHS sites across the UK for the dual benefit of patient care and bio-surveillance.

The lotProcurement structure

single lot · no lot value published

Lot #1Awarded

48814400 Clinical information system 71900000 Laboratory services 73000000 Research and development services and related consultancy services

Procedure terms & legal framework

From the official record

Procedure method: Direct award
Legal basis: UKPGA · 2023/54 Procurement Act 2023
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 19 Dec 2025, 15:45 GMT
Last source update: 17 Feb 2026, 17:01 GMT
Authority reference: C405258
FTS notice number: 2026/S 000-014515
Latest notice: Contract details notice (UK7)
Delivery area: Not published
Official registry OCID: ocds-h6vhtk-05faba Find a Tender

Why no open competition: Single Suppliers Intellectual Property Exclusive Rights; Single Suppliers Technical Reasons
Published justification: Under PA23 there are 2 relevant provisions for a direct award for patented technology covered under section 41, Schedule 5. (1) “a supplier is in possession of IP and there are no reasonable alternatives…”and (2) “the absence of competition for technical reasons”, both sectioned under “Single Suppliers” where a particular supplier owns the intellectual rights and is the only supplier able to provide that product / service.

Notice history

4 events · 3 releases on Find a Tender · since 19 Dec 2025

Transparency notice published
19 Dec 2025, 15:45 GMT
UK5
Contract details notice published
19 Dec 2025, 16:01 GMT
UK7
Contract signature expected
19 Dec 2025, 23:59 GMT
scheduled
Contract details notice published
17 Feb 2026, 17:01 GMT
UK7

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 2

Awarded value £7,010,9661 award exc. VAT

Contracts signed 2latest 21 Nov 2025

Awarded to	Value	Date	Status
Oxford Nanopore Technologies20 Dec 2025 – 8 Dec 2028Options: The Term of this Contract shall expire on the 10th November 2028, unless otherwise extended by agreement in writing by both Parties.	£7,010,966	—	Awarded
Oxford Nanopore Technologies	—	—	Awarded

Contracts

Respiratory Metagenomics Expansion Programme to Oxford Nanopore Technologies · Oxford Nanopore Technologies
Signed
21 Nov 2025
Value
£7,010,966
Period
22 Nov 2025 – 10 Nov 2028
Status
active
Options
The Term of this Contract shall expire on 10th November 2028, unless otherwise extended by agreement in writing by both Parties.
1 agreed KPI: Net Zero Transition Plan and Opportunity and Belonging
- Net Zero Transition Plan and Opportunity and Belonging, There are two KPIs under this contract. Net Zero Transition Plan. We have set interim targets for 2030. Alongside this, we are continuing to take actions to reduce our emissions intensity and have set a target an annual target to reduce emissions by tonnes of CO2e emitted per £m revenue by 2.5percent. Opportunity and Belonging. Continue running events through our Values in Action community, continue to strengthen the skills of our employees through ongoing customised learning and development. Bespoke training solutions will be devised and delivered, and improve EHS resources, implementing additional modules, including documents, training, and checklists, which will enhance the value of the database as a one-stop EHS portal for Oxford Nanopore.
Respiratory Metagenomics Expansion Programme · Oxford Nanopore Technologies
Signed
21 Nov 2025
Value
£6,950,000
Period
21 Nov 2025 – 10 Nov 2028
Status
active
2 agreed KPIs: Net Zero Transition Plan · Opportunity and Belonging
- Net Zero Transition Plan
- Opportunity and Belonging

Contracting authority & participating public bodies

Guy's and St Thomas' NHS Foundation Trust

Contracting authorityPublic authority - central government GB-PPON: PDZC-6438-DGPX Great Maze Pond, London, London, SE1 9RTContact name, email, phone

Bidders & participating suppliers

2 commercial parties on the notice

Oxford Nanopore Technologies PLCAwarded supplierGB-COH: 05386273 Gosling Building Edmund Halley Road, Oxford Science Park, Oxford, South East, OX4 4DQContact email
Oxford Nanopore Technologies PLCAwarded supplierGB-PPON: PNQY-3648-RQHN Gosling Building, Edmund Halley Road, Oxford Science Park,, Oxford, South East, OX4 4DQContact email

Official documents & specifications (4)

Official links; attachments are not copied

Tender pack and attachments

Signed contract contractSigned contractPDFGSTT will lead the development of a national clinical metagenomics pilot service by deploying NHS developed laboratory, bioinformatic and clinical protocols along with Oxford Nanopore developed sequencing technology to a network of 30 NHS sites across the UK for the dual benefit …

Notices published for this procedure

Contract details notice contractContract details noticeUK7Contract details notice on Find a Tender17 Feb 2026, 17:01 GMT
Contract details notice contractContract details noticeUK7Contract details notice on Find a Tender19 Dec 2025, 16:01 GMT
Transparency notice awardTransparency noticeUK5Transparency notice on Find a Tender19 Dec 2025, 15:45 GMT